Go to main content
    • GlobalEN
    • AustriaEN
    • AustriaDE
    • BulgariaEN
    • BulgariaBG
    • Czech RepublicEN
    • Czech RepublicCS
    • GermanyEN
    • GermanyDE
    • EstoniaEN
    • EstoniaET
    • HungaryEN
    • HungaryHU
    • LatviaEN
    • LatviaLV
    • LithuaniaEN
    • LithuaniaLT
    • Middle EastEN
    • PolandEN
    • PolandPL
    • RomaniaEN
    • RomaniaRO
    • SwedenEN
    • SlovakiaEN
    • SlovakiaSK
    • United KingdomEN
By selecting a country, you will see contents with local focus. Contents that are not available in the local language, will be shown in English.
Sweden
    • Our Company

      We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.

      About Our Company
      • Newsroom
        • Meet us
          • Location & Contacts
          • Rare And Special Diseases

            We at AOP Orphan focus on rare diseases particularly in the areas of HematoOncology, Cardiology & Pulmonology, Neurology & Metabolic Disorders. Learn more about the indications, its symptoms, diagnosis, therapies and everyday life here.

            About Rare And Special Diseases
            • HematoOncology
              • Essential Thrombocythemia
                • Polycythaemia Vera
                • Cardiology & Pulmonology
                  • Reversal of opioid-induced respiratory depression
                    • Tachycardia
                      • Septic shock
                      • Neurology & Metabolic Disorders
                        • Huntington's disease
                          • Narcolepsy with or without cataplexy
                            • Primary biliary cholangitis
                          • Individual Treatments

                            Our strategic goal at AOP Orphan is to constantly deliver new treatment options for the patients with rare disease. Learn more about the current product portfolio and countries' availability here.

                            About Individual Treatments
                            • HematoOncology
                              • Anagrelide AOP
                                • BESREMi®
                                • Cardiology & Pulmonology
                                  • Rapibloc®
                                    • Tadalalfil AOP
                                    • Neurology & Metabolic Disorders
                                      • Ocaliva®
                                        • Tetmodis®
                                          • Wakix®
                                            • Naltrexone AOP
                                              • Adepend® Dependex®
                                              • Intensive Care
                                                • Rapibloc ®
                                                  • Empressin ®
                                                    • Empressin®
                                                      • Nexodal
                                                    • Join Us

                                                      Agile, ambitious and aligned team members, mutual appreciation and commitment - this is what makes AOP Orphan a successful company and great place to work. Learn more about the company, open positions and everyday life at AOP Orphan here.

                                                      About Join Us
                                                      • HR Contacts
                                                        • Jobs
                                                      about

                                                      MPN Awareness Day
                                                      Sep 12th, 2019  

                                                      At AOP Orphan, we have been contributing to research on myeloproliferative neoplasms (MPNs) for many years.  On September 12th – the 7th Annual MPN Awareness Day – we especially want to help raising awareness of MPNs, since we believe that informing, connecting and advocating for those who are affected and involved is crucial for the well-being of patients. We will extend these efforts over the following months and bring into focus relevant information, advice and insights on all our communication platforms.

                                                      Content:
                                                      • What are MPNs
                                                      • WHO Classification
                                                      • What is Polycythaemia Vera PV and Essential Thrombocythemia?
                                                      • Home
                                                      • MPN Awareness Day
                                                      Follow us
                                                      Contact us
                                                      AOP Orphan Pharmaceuticals Sweden AB
                                                      Kista Science Tower, Färögatan 33, plan 31
                                                      164 54 Kista , Sweden
                                                      +46 70 5786100
                                                      office.se@aoporphan.com
                                                      © AOP Orphan Pharmaceuticals AG
                                                      • Imprint
                                                      • Disclaimer
                                                      • Privacy Policy
                                                      Created by VERDINO